Back to today’s briefing

Story perspectives

CRISPR Breakthroughs: New Hope for Pediatric Cancer Treatments

5/2/2025

49 10

Summary

Story summary

Associate Professor Paul Ekert is at the forefront of groundbreaking research at the Children's Cancer Institute, harnessing CRISPR technology to target RNA and unveil innovative drug therapies for pediatric cancers. With backing from Luminesce Alliance and NSW Health, this vital work seeks to enhance treatment outcomes and elevate the quality of life for young cancer patients.

1 of 1

Story summary

Associate Professor Paul Ekert is at the forefront of groundbreaking research at the Children's Cancer Institute, harnessing CRISPR technology to target RNA and unveil innovative drug therapies for pediatric cancers. With backing from Luminesce Alliance and NSW Health, this vital work seeks to enhance treatment outcomes and elevate the quality of life for young cancer patients.